Patriot Financial Group Insurance Agency’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-95
Closed -$3K 828
2022
Q2
$3K Sell
95
-20
-17% -$683 ﹤0.01% 1626
2022
Q1
$5K Sell
115
-658
-85% -$29K ﹤0.01% 1595
2021
Q4
$34K Sell
773
-1,127
-59% -$51K 0.01% 1008
2021
Q3
$95K Buy
1,900
+15
+0.8% +$908 0.02% 672
2021
Q2
$119K Buy
1,885
+734
+64% +$47.2K 0.02% 567
2021
Q1
$107K Sell
1,151
-66
-5% -$6.76K 0.02% 531
2020
Q4
$109K Buy
1,217
+1,050
+629% +$96.4K 0.03% 478
2020
Q3
$17K Hold
167
0.01% 851
2020
Q2
$13K Buy
167
+3
+2% +$224 0.01% 880
2020
Q1
$9K Buy
+164
New +$9.45K ﹤0.01% 882
2019
Q4
Sell
-5
Closed 1346
2019
Q3
$0 Hold
5
﹤0.01% 1338
2019
Q2
$1K Hold
5
﹤0.01% 1222
2019
Q1
$0 Hold
5
﹤0.01% 1243
2018
Q4
$0 Buy
+5
New +$322 ﹤0.01% 1012

Other funds holding EBS

Patriot Financial Group Insurance Agency's EBS Position: Q3 2022 in Review

Patriot Financial Group Insurance Agency sold out of Emergent Biosolutions (EBS) in Q3 2022, closing a stake of 95 shares — an estimated $3K sold.

Patriot Financial Group Insurance Agency first reported a position in EBS in Q4 2018 and held it in 14 quarters. The position peaked at $119K in Q2 2021. 211 funds tracked by Wall St. Rank hold EBS as of Q3 2022.

  • Patriot Financial Group Insurance Agency reported no remaining Emergent Biosolutions position as of Q3 2022 after selling out during the quarter.
  • Patriot Financial Group Insurance Agency sold 95 Emergent Biosolutions shares in Q3 2022, an estimated $3K.
  • Patriot Financial Group Insurance Agency first reported a position in Emergent Biosolutions in Q4 2018 and held it in 14 quarters.
  • Patriot Financial Group Insurance Agency's Emergent Biosolutions position peaked at $119K in Q2 2021.
  • 211 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2022.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q3 2022, filed 1 Nov 2022.